+30.4%
GSK vs CPB
-32.6%
+63.0%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CPB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -3.4% | +1.5% | -1.4% |
| 7D | -1.8% | -8.6% | +6.8% | -0.5% |
| 30D | -2.2% | -7.2% | +5.1% | -1.1% |
| 3M | -1.8% | +0.9% | -2.7% | -2.1% |
| 6M | -10.6% | -11.8% | +1.2% | -8.7% |
| YTD | +4.4% | -19.4% | +23.8% | +7.7% |
| 1Y | +30.4% | -30.4% | +60.8% | +38.3% |
| All | +30.4% | -32.6% | +63.0% | +38.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CPB.
Daily Out/Under-Performance
Portfolio return minus CPB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CPB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CPB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling